Lung Cancer Screening Test Saves Lives, Yet Remains… : Oncology Times
An abstract is unavailable.
Related Articles
A Sense of Culture and Community Sparked a Passion in Genitourinary Oncology
A humble mindset of the contributions he has made to genitourinary cancer care, Christopher J. Logothetis, MD, is also working to shape the next generation’s…
5th Surgical Oncology Advanced Practitioner (SOAP) Conference – MDA – Continuing Education (CE)
MDA, 5th Surgical Oncology Advanced Practitioner (SOAP) Conference, 4/24/2025 7:00:00 AM – 4/26/2025 5:30:00 PM, The SOAP (Surgical Oncology Advanced Practitioner) Conference aims to foster…
FDA Approves Tislelizumab Plus Chemo for PD-L1+ Unresectable or Metastatic Gastric/GEJ Cancer
The FDA has approved tislelizumab plus chemotherapy for unresectable or metastatic gastric or gastroesophageal junction adenocarcinoma.
Novel Gene Therapy Approach Uses ‘Stitched’ Together mRNAs… : Neurology Today
An abstract is unavailable.
Resistance Spurs Evaluation of Early-Phase BTK Degraders
During the 66th American Society of Hematology Annual Meeting and Exposition, investigators revealed early-phase 1 data evaluating various BTK degraders that leverage different strategies to…
National Fellows Forum Highlights Future Research Directions in HGSOC and HCC
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
2025 FDA-AACR Workshop: DPD Deficiency and Weighing Potential Harms
AACR is hosting a workshop with the FDA on January 16, 2025, to discuss the considerations for routine testing of DPD deficiency before treatment with…
Uncovering the Power of Introspection to Drive Personalized Cancer Care
A series of events took John L. Marshall, MD, down his path of becoming a gastrointestinal oncology leader, with a drive that has also solidified…